Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine for Reperfusion Injury in STEMI Patients After Primary PCI
NCT06947135Recruiting
- Sponsor
- The Second Affiliated Hospital of Anhui Medical University
- Start
- May 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of morphine in ST-segment elevation myocardial infarction (STEMI) and myocardial reperfusion injury (2 arms), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoint: Percentage of myocardial infarct size at 7 days. Started May 2025; status: recruiting.
02
Drugs
morphine
03
Conditions
ST-segment elevation myocardial infarction (STEMI)myocardial reperfusion injury
Beyond the preview
Go deeper on NCT06947135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06947135.